# A first NAD+ consultation: evidence and expectations

For frequent travelers considering NAD+, the important questions are what is causing fatigue, which product is proposed and what evidence supports it.

Canonical: https://velri.co/blog/first-nad-consult-road-warrior-what-to-expect-first-weeks
Publisher: Velri (https://velri.co/about)
Published: 2026-07-25
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

A useful NAD+ consultation should begin with the reason you are seeking it. For frequent travelers, that may be daytime sleepiness, difficulty concentrating or fatigue that continues after a trip. Those experiences need a clearer description before they can be matched to a treatment. [1]

NAD+ has an essential role in cellular metabolism. Research into that role is substantial; evidence that a particular NAD+ treatment will improve a traveler's energy is a separate question. [2]

## What research can and cannot establish

One small randomized study in healthy middle-aged and older adults found that an oral NAD+ precursor, nicotinamide riboside, increased measures of NAD+ metabolism. The trial studied that precursor and its physiological effects, not injectable NAD+ as a remedy for jet lag or a demanding travel schedule. [3]

A review of NAD+ biology also describes unanswered questions about translating this research into safe, beneficial treatment for human aging. A consultation should explain that uncertainty when discussing expected benefits. [2]

## The product details matter

A consultation should identify the proposed ingredient, formulation and route, then explain which human studies apply to it. The route matters because the cited trial studied an oral precursor, not an injection. [3]

If the proposed preparation is compounded, it is not FDA approved. The FDA does not evaluate compounded drugs for safety, effectiveness or quality before marketing. [4]

## Define the problem before measuring a result

Sleep opportunity, awakenings, work hours and medication use can help explain fatigue. Other possibilities include anemia, thyroid disease and sleep disorders; testing depends on the history and examination. [1]

For a traveler, a simple record of sleep timing, travel dates and the specific problem is useful context. “I need to sleep at afternoon meetings” describes something different from “my muscles feel exhausted after ordinary activity.” MedlinePlus distinguishes drowsiness from a lack of energy. [1]

Any proposed plan should explain what improvement would mean, how it would be assessed and what follow-up would happen if symptoms persisted. An expectation such as “more cellular energy” is too vague to tell you whether the problem that brought you in has changed.

## Sources
[1] Fatigue: MedlinePlus Medical Encyclopedia (2025). https://medlineplus.gov/ency/article/003088.htm
[2] NAD+ metabolism and its roles in cellular processes during ageing (2021). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963035/
[3] Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876407/
[4] Compounding and the FDA: Questions and Answers | FDA (2025). https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support